RAPP
#2166
Rapport Therapeutics, Inc. - Common Stock
30.1 5 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.63%
Monthly Change
-31.94%
6 month change
-13.46%
Year Change
+15.12%
Previous Close
30.6 5
Open
30.5 7
Low
30.1 0
High
30.7 1
Financials
2026
Current report, Q3 FY2026
Rapport Therapeutics, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Rapport Therapeutics, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Rapport Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Rapport Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Rapport Therapeutics, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Rapport Therapeutics, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Rapport Therapeutics, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Rapport Therapeutics, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Rapport Therapeutics, Inc. current report, Q1 FY2026
8-K
2025
Annual report, FY2025
Rapport Therapeutics, Inc. annual report, FY2025
10-K